Brain Metastases, Adult Clinical Trials

26 recruiting

Brain Metastases, Adult Trials at a Glance

26 actively recruiting trials for brain metastases, adult are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Phase 2 with 11 trials, with the heaviest enrollment activity in New York, Miami, and Sankt Gallen. Lead sponsors running brain metastases, adult studies include Baptist Health South Florida, Ayal A. Aizer, MD, and Memorial Sloan Kettering Cancer Center.

Browse brain metastases, adult trials by phase

Treatments under study

About Brain Metastases, Adult Clinical Trials

Looking for clinical trials for Brain Metastases, Adult? There are currently 26 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Brain Metastases, Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Brain Metastases, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 26 trials

Recruiting
Not Applicable

Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases

Brain Metastases, Adult
Istituto Clinico Humanitas146 enrolled9 locationsNCT05545007
Recruiting
Phase 1

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Brain Metastases, AdultBrain MetastasesBrain Cancer
Baptist Health South Florida20 enrolled1 locationNCT04689048
Recruiting
Phase 2

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

Brain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+1 more
Ayal A. Aizer, MD60 enrolled1 locationNCT07132190
Recruiting
Phase 2

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Brain Metastases, AdultBrain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases From Extra-cranial Solid Tumors+2 more
Ayal A. Aizer, MD150 enrolled1 locationNCT07130786
Recruiting

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

Brain Metastases, AdultBrain MetastasesMetastatic Brain Tumor+1 more
Memorial Sloan Kettering Cancer Center119 enrolled1 locationNCT05559853
Recruiting
Phase 1Phase 2

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

CancerMetastatic CancerMetastasis+2 more
Baptist Health South Florida46 enrolled1 locationNCT05789589
Recruiting
Phase 2

Brain Imaging Biomarkers in Patients With Brain Metastasis

Brain Metastases, Adult
University Health Network, Toronto90 enrolled1 locationNCT04197297
Recruiting
Not Applicable

Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases

Brain Metastases, Adult
Susanne Rogers200 enrolled10 locationsNCT05124236
Recruiting
Phase 1Phase 2

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Cervical CancerBrain Metastases, AdultDiffuse Astrocytoma, IDH-Mutant+1 more
Neonc Technologies, Inc.134 enrolled6 locationsNCT06047379
Recruiting
Phase 2

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Lung CancerBrain Metastases, AdultBrain Metastases+1 more
Memorial Sloan Kettering Cancer Center62 enrolled7 locationsNCT05419076
Recruiting
Not Applicable

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

Breast CarcinomaMelanomaNon-small Cell Lung Cancer+4 more
Wake Forest University Health Sciences244 enrolled39 locationsNCT05703269
Recruiting
Not Applicable

Multi-disciplinary Care for Brain Metastases

Brain Metastases, Adult
University of Vermont Medical Center40 enrolled1 locationNCT06280300
Recruiting
Phase 2

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

Brain Metastases, AdultBrain Metastases
University of Zurich102 enrolled3 locationsNCT06620380
Recruiting
Phase 1Phase 2

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Breast CancerBrain Metastases, Adult
Colette Shen41 enrolled7 locationsNCT04711824
Recruiting

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Brain Metastases, AdultBrain Tumor, Primary
Duke University300 enrolled1 locationNCT05480644
Recruiting

AI-assisted Diagnosis of Malignant Brain Tumors

Brain Metastases, AdultLymphomaGliomas+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University3,000 enrolled2 locationsNCT07198256
Recruiting

Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Colorectal Cancer

Brain Metastases, AdultColorectal Cancer Metastatic
Blokhin's Russian Cancer Research Center30 enrolled1 locationNCT06449989
Recruiting
Phase 1

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

Brain Metastases, AdultBrain MetastasesBrain Cancer
Baptist Health South Florida46 enrolled1 locationNCT06048094
Recruiting
Phase 2

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Brain Metastases, AdultNSCLC Stage IV
Maastricht University Medical Center25 enrolled3 locationsNCT06401824
Recruiting
Phase 2

RAPid SimPLE Targeted Radiation Treatment for Brain Metastases

Brain Metastases, Adult
British Columbia Cancer Agency100 enrolled6 locationsNCT05050929